The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Open accessAbstract
Objective: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE. Methods: The classification criteria were derived from a set of 702 expert‐rated patient scenarios. Recursive partitioning was used to derive an initial rule that was simplified and refined based on SLICC physician consensus. The SLICC group validated the classification criteria in a new validation sample of 690 new expert‐rated patient scenarios. Results: Seventeen criteria were identified. In the derivation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (49 versus 70; P = 0.0082) and had greater sensitivity (94% versus 86%; P < 0.0001) and equal specificity (92% versus 93%; P = 0.39). In the validation set, the SLICC classification criteria resulted in fewer misclassifications compared with the current ACR classification criteria (62 versus 74; P = 0.24) and had greater sensitivity (97% versus 83%; P < 0.0001) but lower specificity (84% versus 96%; P < 0.0001). Conclusion: The new SLICC classification criteria performed well in a large set of patient scenarios rated by experts. According to the SLICC rule for the classification of SLE, the patient must satisfy at least 4 criteria, including at least one clinical criterion and one immunologic criterion OR the patient must have biopsy‐proven lupus nephritis in the presence of antinuclear antibodies or anti–double‐stranded DNA antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Systemic Lupus International Collaborating Clinics (SLICC) criteria published in 2012 showed that, although highly specific, the sensitivity of the ACR classification criteria for SLE was suboptimal, especially in new-onset SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, anti-dsDNA testing is an essential part of the diagnosis, classification, and management of SLE (2,3,(11)(12)(13)”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These criteria proposed to classify only patients that have at least one immunologic criterion, overcoming SLE classification based solely on clinical manifestations.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Accordingly, patients without the listed autoantibodies or low complement cannot be classified as having SLE.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“new classification criteria for SLE were issued in 2012 by the Systemic Lupus International Collaborating Clinics (SLICC)”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The new SLICC classification criteria contain several novelties compared to the ACR criteria [18].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“The existence of anti-dsDNA Abs in the absence of positive ANA results is thought to be a rare phenomenon that is attributed to laboratory errors [40].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“SLE patients were diagnosed according to revised ACR and SLICC criteria [23, 24].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Since 2012, the IgA isotype of the aPL has been accepted as a laboratory criterion for SLE in the SLICC SLE Classification Criteria [23].”
From Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus (2021) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“The included studies used ACR 1982 (33), ACR 1997 (13), SLICC 2012 (3), or a combination of these classification criteria to define the SLE group.”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,867
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H. K., Deyo, R. A., Gabriel, S. E., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,599
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Gladman, D. D., Ginzler, E. M., Goldsmith, C. H., Fortin, P. R., Liang, M. H., Sánchez‐Guerrero, J., Urowitz, M. B., Bacon, P., Bombardieri, S., Hanly, J. G., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,589
Self-citationNavarra, S., Guzmán, R., Gallacher, A., Hall, S., Levy, R. A., Jimenez, R., Li, E. K., Thomas, M., Kim, H., Leon, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,078
Self-citationEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S. E., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,054
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Weening, J. J., ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T. H., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00443.x · Cited by 1,649
Self-citation
Flagged first, then by citations
2 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,011
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study
Sebastiani, M., Cassone, G., Pasquale, L. D., Cerri, S., Casa, G. D., Vacchi, C., Luppi, F., Salvarani, C., & Manfredi, A. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102451 · Cited by 46
Differentiating between UCTD and early-stage SLE: from definitions to clinical approach
Sciascia, S., Roccatello, D., Radin, M., Parodis, I., Yazdany, J., Pons‐Estel, G., & Mosca, M. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00710-2 · Cited by 46
Iudici, M., Fasano, S., Falcone, L. G., Pantano, I., MONTAGNA, G. L., Migliaresi, S., & Valentini, G. (2016) · Rheumatology · doi:10.1093/rheumatology/kew231 · Cited by 46
Teh, P., Zakhary, B. L., & Sandhu, V. K. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4336-3 · Cited by 46
Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey
Otter, S. J., Kumar, S., Gow, P. J., Dalbeth, N., Corkill, M., Rohan, M., Davies, K. A., Pankathelam, S., & Rome, K. (2016) · Journal of Foot and Ankle Research · doi:10.1186/s13047-016-0143-8 · Cited by 45
Chang, L., Huang, P., Kuo, H., Tu, Y., Tseng, P., Liang, C., & Hsu, C.-W. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103144 · Cited by 45
Predictors of recurrence following an initial episode of transverse myelitis
Kimbrough, D. J., Mealy, M. A., Simpson, A. C., & Levy, M. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000004 · Cited by 45
Fanouriakis, A., Mastorodemos, V. C., Pamfil, C. A. M., Papadaki, E. Z., Sidiropoulos, P. I., Plaitakis, A., Amoiridis, G., Bertsias, G. K., & Boumpas, D. T. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.11.007 · Cited by 45
Fukui, S., Iwamoto, N., Umeda, M., Nishino, A., Nakashima, Y., Koga, T., Kawashiri, S., Ichinose, K., Hirai, Y., Tamai, M., et al. (2016) · Medicine · doi:10.1097/md.0000000000004871 · Cited by 45
Brain diffusion tensor MRI in systematic lupus erythematosus: A systematic review
Costallat, B. L., Ferreira, D. M., Lapa, A. T., Rittner, L., Costallat, L. T. L., & Appenzeller, S. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.008 · Cited by 45
Troldborg, A., Jensen, L., Deleuran, B. W., Stengaard‐Pedersen, K., Thiel, S., & Jensenius, J. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00581 · Cited by 45
Tarvin, S. E., & O’Neil, K. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.04.001 · Cited by 45
Interstitial Pneumonia With Autoimmune Features
Wilfong, E. M., Lentz, R. J., Guttentag, A. R., Tolle, J., Johnson, J. E., Kropski, J. A., Kendall, P. L., Blackwell, T. S., & Crofford, L. J. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40679 · Cited by 45
Guo, Q., Wu, L., Wang, Z., Shen, J., Su, X., Wang, C., Gong, X., Yan, Q., He, Q., Zhang, W., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40671 · Cited by 45
Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus
Zayat, A. S., Mahmoud, K. M., Yusof, M. Y. M., Mukherjee, S., D’Agostino, M. A., Hensor, E. M. A., Wakefield, R. J., Conaghan, P. G., Edwards, C. J., Emery, P., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/key277 · Cited by 45
Nystedt, J., Mannfolk, P., Jönsen, A., Nilsson, P., Strandberg, T. O., & Sundgren, P. C. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24656 · Cited by 45
Lonati, P. A., Scavone, M., Gerosa, M., Borghi, M. O., Pregnolato, F., Curreli, D., Podda, G. M., Femia, E. A., Barcellini, W., Cattaneo, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00773 · Cited by 45
Lupus erythematosus tumidus: clinical perspectives
Patsinakidis, N., Kautz, O., Gibbs, B. F., & Raap, U. (2019) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s166723 · Cited by 45
Ahn, S. S., Jung, S. M., Yoo, J., Lee, S., Song, J. J., & Park, Y. (2019) · Rheumatology International · doi:10.1007/s00296-019-04445-y · Cited by 45
Hamijoyo, L., Candrianita, S., Rahmadi, A. R., Dewi, S., Darmawan, G., Suryajaya, B. S., Rainy, N., Hidayat, I. I., Moenardi, V., & Wachjudi, R. G. (2019) · Lupus · doi:10.1177/0961203319878499 · Cited by 45
Uric acid and kidney damage in systemic lupus erythematosus
dos Santos, M., Veronese, F. V., & Moresco, R. N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.034 · Cited by 45
Kim, J.-W., Jung, J., Kim, H., Yang, J. I., Kwak, D. W., & Suh, C. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200802 · Cited by 45
Sippl, N., Faustini, F., Rönnelid, J., Turcinov, S., Chemin, K., Gunnarsson, I., & Malmström, V. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13585 · Cited by 45
Robinson, G., Waddington, K. E., Coelewij, L., Peng, J., Naja, M., Wincup, C., Radziszewska, A., Peckham, H., Isenberg, D. A., Ioannou, Y., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103243 · Cited by 45
Self-citationAnderson, E., Fishbein, J. S., Hong, J., Roeser, J., Furie, R. A., Aranow, C. B., Volpe, B. T., Diamond, B., & Mackay, M. C. (2021) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000559 · Cited by 49
Self-citationDeconvoluting virome-wide antibody epitope reactivity profiles
Monaco, D. R., Kottapalli, S., Breitwieser, F. P., Anderson, D. E., Wijaya, L., Tan, K., Chia, W. N., Kammers, K., Caturegli, P., Waugh, K., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103747 · Cited by 46
Self-citationGarcía, M., Alarcón, G. S., Boggio, G. S., Hachuel, L. S., Marcos, A. I., Marcos, J. C., Gentiletti, S., Caeiro, F., Sato, E. I., Borba, E. F., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/keu011 · Cited by 44
Self-citationCurrent status of lupus nephritis
Jaryal, A., & Vikrant, S. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_163_16 · Cited by 44
Diagnostic and prognostic tests in systemic lupus erythematosus
Vasquez‐Canizares, N., Wahezi, D. M., & Putterman, C. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.10.002 · Cited by 44
Definition of NPSLE: Does the ACR Nomenclature Still Hold?
Vivaldo, J. F., de Amorim, J. C., Júlio, P. R., de Oliveira, R. J., & Appenzeller, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00138 · Cited by 44
Lei, L., Muhammad, S., Obaidi, M. A., Sebire, N. J., Cheng, I. L., Eleftheriou, D., & Brogan, P. A. (2018) · Pediatric Rheumatology · doi:10.1186/s12969-018-0278-1 · Cited by 44
Mohamed, A. A. A., Hammam, N., Zohri, M. H. E., & Gheita, T. A. (2019) · BioMed Research International · doi:10.1155/2019/2437105 · Cited by 44
Keramiotou, K., Anagnostou, C., Kataxaki, E., Γαλανός, Α., Sfikakis, P. P., & Tektonidou, M. G. (2020) · RMD Open · doi:10.1136/rmdopen-2019-001141 · Cited by 44
Hanset, N., Aydın, S., Demoulin, N., Cosyns, J., Castanares‐Zapatero, D., Crott, R., Cambier, J., Pochet, J.-M., Gillerot, G., Reginster, F., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.04.013 · Cited by 44
Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives
Tang, S. P., Lim, S. C., & Arkachaisri, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040559 · Cited by 44
Self-citationSun, L., Shen, Q., Gong, Y., Li, Y., Lv, Q., Liu, H., Zhao, F., Yu, H., Qiu, L., Li, X., et al. (2022) · Lupus · doi:10.1177/09612033221097812 · Cited by 44
Dörner, T., van Vollenhoven, R., Doria, A., Jia, B., Terres, J. A. R., Silk, M. E., de Bono, S., Fischer, P., & Wallace, D. J. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02794-x · Cited by 44
Self-citationKuhn, A., Landmann, A., & Bonsmann, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00041-6 · Cited by 44
Exhausted T cells in systemic lupus erythematosus patients in long-standing remission
Lima, G., Treviño-Tello, F., Atisha‐Fregoso, Y., Llorente, L., Fragoso-Loyo, H. E., & Jakez‐Ocampo, J. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13577 · Cited by 46
Pitsigavdaki, S., Nikoloudaki, M., Garantziotis, P., Silvagni, E., Repa, A., Marangoni, A., Flouri, I. D., Avgoustidis, N., Parperis, K. M., Fanouriakis, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224919 · Cited by 43
Pain and systemic lupus erythematosus
Franco, M. D., Guzzo, M. P., Spinelli, F. R., Atzeni, F., Sarzi‐Puttini, P., Conti, F., & Iannuccelli, C. (2014) · Reumatismo · doi:10.4081/reumatismo.2014.762 · Cited by 43
Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care
Choi, M. Y., Barber, M. R. W., Barber, C. E. H., Clarke, A. E., & Fritzler, M. J. (2016) · Lupus · doi:10.1177/0961203316640367 · Cited by 43
Self-citationPiga, M., Saba, L., Gabba, A., Congia, M., Balestrieri, A., Mathieu, A., & Cauli, A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1125-8 · Cited by 43
Olsen, N. J., James, J. A., Arriens, C., ISHIMORI, M. L., Wallace, D. J., Kamen, D. L., Chong, B. F., Liao, D., Chinchilli, V. M., & Karp, D. R. (2018) · Trials · doi:10.1186/s13063-018-3076-7 · Cited by 43
Self-citationFrodlund, M., Reid, S., Wetterö, J., Dahlström, Ö., Sjöwall, C., & Leonard, D. (2019) · Lupus · doi:10.1177/0961203319860198 · Cited by 43
Louthrenoo, W., Kasitanon, N., Morand, E. F., & Kandane‐Rathnayake, R. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2095-4 · Cited by 43
Chen, Y., Chang, J., Lai, E. L., Liao, T., Chen, H., Hung, W., Hsieh, T., Huang, W., Chen, Y., Lin, C., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.01.014 · Cited by 43
Domínguez-Casas, L., Sánchez-Bilbao, L., Calvo-Río, V., Maiz, O., Blanco, A., Beltrán, E., Costa, L. M., Demetrio‐Pablo, R., del Buergo, M. Á., Rubio‐Romero, E., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.03.023 · Cited by 43
Pregnancy outcomes in patients treated with belimumab: Report from real-world experience
Kao, J., Lan, T., Lu, C., Cheng, C., Huang, Y., Shen, C., & Hsieh, S. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.06.005 · Cited by 43
Mähler, M., & Dervieux, T. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205324 · Cited by 43
Rekvig, O. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569234 · Cited by 42
Long-term renal survival of paediatric patients with lupus nephritis
Demir, S., Gülhan, B., Özen, S., Çeleğen, K., Batu, E. D., Taş, N., Orhan, D., Bilginer, Y., Düzova, A., Özaltın, F., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab152 · Cited by 42
Lim, S. S., & Drenkard, C. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000198 · Cited by 42
Self-citationAberle, T., Bourn, R. L., Munroe, M. E., Chen, H., Roberts, V., Guthridge, J. M., Bean, K. M., Robertson, J. M., Sivils, K. L. M., Rasmussen, A., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23201 · Cited by 42
Self-citationBone marrow involvement in systemic lupus erythematosus
Chalayer, É., Costedoat-Chalumeau, N., Beyne‐Rauzy, O., Ninet, J., Durupt, S., Tebib, J.-G., Asli, B., Lambotte, O., Ffrench, M., Vasselon, C., et al. (2017) · QJM · doi:10.1093/qjmed/hcx102 · Cited by 42
SLICC damage index score in systemic lupus erythematosus patients and its associated factors
Ghazali, W. S. W., Daud, S. M. M., Mohammad, N., & Wong, K. K. (2018) · Medicine · doi:10.1097/md.0000000000012787 · Cited by 42
Lupus thrombocytopenia: pathogenesis and therapeutic implications
Galanopoulos, N. G., Christoforidou, A., & Bezirgiannidou, Z. (2017) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.28.1.20 · Cited by 42
Lambers, W. M., Westra, J., Bootsma, H., & de Leeuw, K. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200726 · Cited by 42
Chanprapaph, K., Tankunakorn, J., Suchonwanit, P., & Rutnin, S. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00471-y · Cited by 42
Zhu, J., Wang, T., Lin, Y., Xiong, M., Chen, J., Jian, C., Zhang, J., Xie, H., Zeng, F., Huang, Q., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.931431 · Cited by 43
Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/902821 · Cited by 41
Rajasinghe, L. D., Li, Q., Zhu, C., Yan, M., Chauhan, P., Wierenga, K. A., Bates, M. A., Harkema, J. R., Benninghoff, A. D., & Pestka, J. J. (2020) · Autoimmunity · doi:10.1080/08916934.2020.1801651 · Cited by 42
Hidaka, D., Ogasawara, R., Sugimura, S., Fujii, F., Kojima, K., Nagai, J., Ebata, K., Okada, K., Kobayashi, N., Ogasawara, M., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03243-2 · Cited by 42
Aikawa, N. E., Kupa, L. D. V. K., Ribeiro, A. C. D. M., Saad, C. G. S., Yuki, E. F. N., Pasoto, S. G., Rojo, P. T., Pereira, R. M. R., Shinjo, S. K., Sampaio-Barros, P. D., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-222096 · Cited by 41
Fava, A., Wagner, C. A., Guthridge, C. J., Kheir, J. M., Macwana, S., DeJager, W., Gross, T. F., Izmirly, P., Belmont, M. H., Diamond, B., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42941 · Cited by 41
Self-citationMehra, S., & Fritzler, M. J. (2014) · Journal of Immunology Research · doi:10.1155/2014/368274 · Cited by 42
Medical Conditions with Neuropsychiatric Manifestations
Isaac, M., & Larson, E. B. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.012 · Cited by 41
Multiparametric detection of autoantibodies in systemic lupus erythematosus
Budde, P. I., Zucht, H.-D., Vordenbäumen, S., Goehler, H., Fischer‐Betz, R., Gamer, M., Marquart, K., Rengers, P., Richter, J., Lueking, A., et al. (2016) · Lupus · doi:10.1177/0961203316641770 · Cited by 41
Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus
do Nascimento, N. M., Juste-Dolz, A., Grau-García, E., Román‐Ivorra, J. A., Puchades, R., Maquieira, Á., Morais, S., & Giménez-Romero, D. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.11.004 · Cited by 41
Incidence and prevalence of systemic lupus erythematosus among the native Arab population in UAE
Dhanhani, A. M. A., Agarwal, M., Othman, Y., & Bakoush, O. (2016) · Lupus · doi:10.1177/0961203316678677 · Cited by 41
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients
Isenberg, D. A., Sturgess, J., Allen, E., Aranow, C. B., Askanase, A., Sang‐Cheol, B., Bernatsky, S., Bruce, I. N., Buyon, J. P., Cervera, R., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23252 · Cited by 41
Self-citationJuvenile lupus: Different clinical and serological presentations compared to adult lupus in Egypt
Mohamed, D. F., Eldin, A. B., Hassan, S. A.-M., Shedid, N. H., El-Owaidy, R. H., & Teama, M. A. E. M. (2017) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2017.04.004 · Cited by 41
Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE
Petri, M., Conklin, J., O’Malley, T., & Dervieux, T. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000318 · Cited by 41
Self-citationAbbara, S., Séror, R., Henry, J., Chrétien, P., Gleizes, A., Hacein‐Bey‐Abina, S., Mariette, X., & Nocturne, G. (2019) · RMD Open · doi:10.1136/rmdopen-2019-001033 · Cited by 41
Drosos, G. C., Konstantonis, G. D., Sfikakis, P. P., & Tektonidou, M. G. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa256 · Cited by 42
Chan, K., & Mok, C. (2013) · Lupus · doi:10.1177/0961203313500550 · Cited by 41
Hawro, T., Bogucki, A., Krupińska-Kun, M., Maurer, M., & Woźniacka, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119911 · Cited by 41
Judson, M. A. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000596 · Cited by 41
The clinical and laboratory manifestations of systemic lupus erythematosus
Klyukvina, N. G., & Nasonov, E. L. (2012) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2012-761 · Cited by 41
Chung, C.-W., Hsiao, T., Huang, C.-J., Chen, Y., Chen, H.-H., Lin, C., Chou, S.-C., Chen, T.-S., Chung, Y.-F., Yang, H., et al. (2021) · BioData Mining · doi:10.1186/s13040-021-00284-5 · Cited by 40
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium
Ceccarelli, F., Govoni, M., Piga, M., Cassone, G., Cantatore, F. P., Olivieri, G., Cauli, A., Favalli, E. G., Atzeni, F., Gremese, E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206016 · Cited by 44
Application of Machine Learning Models in Systemic Lupus Erythematosus
Ceccarelli, F., Natalucci, F., Picciariello, L., Ciancarella, C., Dolcini, G., Gattamelata, A., Alessandri, C., & Conti, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054514 · Cited by 42
Ungprasert, P., Sagar, V., Crowson, C. S., Amin, S., Makol, A., Ernste, F. C., Osborn, T. G., Moder, K. G., Niewold, T. B., Kremers, H. M., et al. (2016) · Lupus · doi:10.1177/0961203316657434 · Cited by 40
Self-citationDNA repair and systemic lupus erythematosus
Meas, R., Burak, M. J., & Sweasy, J. B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.020 · Cited by 42
Predictors of predominant Lupus Low Disease Activity State (LLDAS-50)
Babaoğlu, H., Li, J., GOLDMAN, D. W., Magder, L. S., & Petri, M. (2019) · Lupus · doi:10.1177/0961203319886028 · Cited by 40
Self-citationSuda, M., Kishimoto, M., Ohde, S., & Okada, M. (2020) · Clinical Rheumatology · doi:10.1007/s10067-019-04848-z · Cited by 40
Drosos, G. C., Konstantonis, G. D., Sfikakis, P. P., & Tektonidou, M. G. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320906650 · Cited by 41
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE
Garcia, L. P. W., Gladman, D. D., Urowitz, M. B., Touma, Z., Su, J., & Johnson, S. R. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218670 · Cited by 40
Self-citationClinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China
Zhang, S., Li, M., Zhang, L., Wang, Z., Wang, Q., You, H., Wang, Y., Li, M., & Zeng, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/1349042 · Cited by 40
Simon, Q., Grasseau, A., Boudigou, M., Pottier, L. L., Bettacchioli, É., Cornec, D., Rouvière, B., Jamin, C., Lann, L. L., PRECISESADS Flow Cytometry Study Group, et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41697 · Cited by 40
Kuna, A. T., Đerek, L., Drvar, V., Kozmar, A., & Gugo, K. (2021) · Biochemia Medica · doi:10.11613/bm.2021.020502 · Cited by 40
Saadoun, D., Vieira, M., Vautier, M., Baraliakos, X., Andreica, I., da Silva, J. A. P., Sousa, M., Luís, M., Khmelinskii, N., Gracia, J. M. A., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00112-0 · Cited by 40
Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis
Qiu, S., Zhang, H., Yu, S., Yang, Q., Zhang, G., Yang, H., Li, Q., & Wang, M. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05164-y · Cited by 40
Roussotte, M., Gerfaud‐Valentin, M., Hot, A., Audia, S., Bonnotte, B., Thibault, T., Lobbes, H., Guenno, G. L., Goulabchand, R., Cathébras, P. J., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab925 · Cited by 40
Caza, T. N., Wijewardena, C., Al-Rabadi, L. F., & Perl, A. (2022) · Translational research · doi:10.1016/j.trsl.2022.03.004 · Cited by 40
S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus
Kim, J.-W., Jung, J., Lee, S., Baek, W., Kim, H., & Suh, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886209 · Cited by 40
Saraiva, S. D. S., Custódio, I., Mazetto, B. D. M., Colella, M. P., Paula, E. V. D., Appenzeller, S., Annichino-Bizzachi, J., & Orsi, F. A. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.10.029 · Cited by 40
Preclinical Systemic Lupus Erythematosus
Robertson, J. M., & James, J. A. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.07.004 · Cited by 40
Rekvig, O. P., van der Vlag, J., & Seredkina, N. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38365 · Cited by 39
Ocular involvement in systemic lupus erythematosus
Preble, J. M., Silpa‐archa, S., & Foster, C. S. (2015) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000209 · Cited by 39
Metadata
- Authors
- Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey‐Goldman, R., Bae, S., Hanly, J. G., Sánchez‐Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., Gladman, D., Kalunian, K., Costner, M., Werth, V. P., Zoma, A., Bernatsky, S., Ruiz‐Irastorza, G., Khamashta, M. A., Jacobsen, S., Buyon, J. P., Maddison, P., Dooley, M. A., van Vollenhoven, R. F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J. L., Callen, J. P., Lim, S. S., Fessler, B. J., Inanc, M., Kamen, D. L., Rahman, A., Steinsson, K., Franks, A. G., Sigler, L., Hameed, S., Fang, H., Pham, N., Brey, R., Weisman, M. H., McGwin, G., & Magder, L. S.
- Affiliations
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Birmingham (GB)
- Oklahoma Medical Research Foundation (US)
- Centre hospitalier universitaire de Québec (CA)
- Manchester Academic Health Science Centre (GB)
- Cedars-Sinai Medical Center (US)
- Skåne University Hospital (SE)
- Northwestern University (US)
- Dalhousie University (CA)
- Mount Sinai Hospital (CA)
- Feinstein Institute for Medical Research (US)
- Toronto Western Hospital (CA)
- University of California San Diego (US)
- University of Pennsylvania (US)
- Hairmyres Hospital (GB)
- McGill University Health Centre (CA)
- University of the Basque Country (ES)
- St Thomas' Hospital (GB)
- New York University (US)
- Ysbyty Gwynedd Hospital NHS Trust (GB)
- University of North Carolina at Chapel Hill (US)
- Karolinska University Hospital (SE)
- SUNY Downstate Health Sciences University (US)
- Spitäler Schaffhausen (CH)
- Atrium Health Wake Forest Baptist (US)
- University of Louisville (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Petri, Michelle
- ORCID
- Petri, Michelle
- Orbai, Ana‐Maria
- Alarcón, Graciela S.
- Gordon, Caroline
- Merrill, Joan T.
- Fortin, Paul R.
- Bruce, Ian N.
- Isenberg, David
- Wallace, Daniel J.
- Nived, Ola
- Ramsey‐Goldman, Rosalind
- Bae, Sang‐Cheol
- Hanly, John G.
- Sánchez‐Guerrero, Jorge
- Clarke, Ann
- Aranow, Cynthia
- Manzi, Susan
- Urowitz, Murray
- Gladman, Dafna
- Kalunian, Kenneth
- Werth, Victoria P.
- Bernatsky, Sasha
- Ruiz‐Irastorza, Guillermo
- Khamashta, Munther A.
- Buyon, Jill P.
- Maddison, Peter
- Ginzler, Ellen
- Stoll, Thomas
- Peschken, Christine
- Jorizzo, Joseph L.
- Callen, Jeffrey P.
- Lim, S. Sam
- Kamen, Diane L.
- Rahman, Anisur
- Franks, Andrew G.
- Fang, Hong
- Brey, Robin
- Weisman, Michael H.
- McGwin, Gerald
- Magder, Laurence S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-07-27
- Volume
- 64
- Issue
- 8
- Pages
- 2677-2686
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC3409311
- OpenAlex
- W2159860161
- Cited by
- 5,322
- References
- 38
- Citations by year
- 2026: 322 · 2025: 421 · 2024: 454 · 2023: 507 · 2022: 550 · 2021: 572 · 2020: 524 · 2019: 450 · 2018: 415 · 2017: 343 · 2016: 282 · 2015: 220 · 2014: 163 · 2013: 78 · 2012: 13
- FWCI
- 116.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000150)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR043727, U01AR051871, T32AR048522)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, SLICC criteria, ACR classification criteria, diagnostic accuracy, sensitivity and specificity, recursive partitioning, lupus nephritis, antinuclear antibodies, anti-dsDNA antibodies
- MeSH terms
- Antibodies, Anti-Idiotypic, Antibodies, Antinuclear, Biopsy, DNA, Humans, International Agencies, Lupus Erythematosus, Systemic, Lupus Nephritis, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
